These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 1341991)

  • 1. Management of psychotropic-induced hyperprolactinemia.
    Marken PA; Haykal RF; Fisher JN
    Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperprolactinemia associated with psychotropics--a review.
    Madhusoodanan S; Parida S; Jimenez C
    Hum Psychopharmacol; 2010; 25(4):281-97. PubMed ID: 20521318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
    Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
    Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switch to quetiapine in antipsychotic agent-related hyperprolactinemia.
    Keller R; Mongini F
    Neurol Sci; 2002 Dec; 23(5):233-5. PubMed ID: 12522680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia.
    Yuan HN; Wang CY; Sze CW; Tong Y; Tan QR; Feng XJ; Liu RM; Zhang JZ; Zhang YB; Zhang ZJ
    J Clin Psychopharmacol; 2008 Jun; 28(3):264-370. PubMed ID: 18480682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic-induced hyperprolactinemia.
    Bostwick JR; Guthrie SK; Ellingrod VL
    Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication-induced hyperprolactinemia.
    Molitch ME
    Mayo Clin Proc; 2005 Aug; 80(8):1050-7. PubMed ID: 16092584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
    Holzer L; Eap CB
    J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The assessment of the mental state of patients during simultaneous treatment with psychotropic drugs, antipsychotics included, and bromocriptine].
    Barszcz Z; Mucha S; Rabe-Jabłońska J
    Psychiatr Pol; 2008; 42(4):595-607. PubMed ID: 19189603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
    Compton MT; Miller AH
    Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic-associated hyperprolactinemia. Can it be treated with bromocriptine?
    Smith S
    J Reprod Med; 1992 Aug; 37(8):737-40. PubMed ID: 1359137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Endocrinologic adverse effects of psychotropic drugs].
    Elenitza IM
    Vertex; 2005; 16(59):43-8. PubMed ID: 15785788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotropic-induced hyperprolactinemia: a clinical review.
    Ajmal A; Joffe H; Nachtigall LB
    Psychosomatics; 2014; 55(1):29-36. PubMed ID: 24140188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amantadine in the treatment of neuroendocrine side effects of neuroleptics.
    Correa N; Opler LA; Kay SR; Birmaher B
    J Clin Psychopharmacol; 1987 Apr; 7(2):91-5. PubMed ID: 2884239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
    Byerly M; Suppes T; Tran QV; Baker RA
    J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
    Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
    J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report.
    Gioia P; Asnis G
    J Clin Psychiatry; 1988 Jan; 49(1):29-31. PubMed ID: 2891689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching female schizophrenic patients to quetiapine from conventional antipsychotic drugs: effects on hyperprolactinemia.
    Nakajima M; Terao T; Iwata N; Nakamura J
    Pharmacopsychiatry; 2005 Jan; 38(1):17-9. PubMed ID: 15706461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose risperidone augmentation of antidepressants or anxiolytics is associated with hyperprolactinemia.
    Kopecek M; Bares M; Horacek J; Mohr P
    Neuro Endocrinol Lett; 2006 Dec; 27(6):803-6. PubMed ID: 17187006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperprolactinemia].
    König MP; Kopp P
    Schweiz Med Wochenschr; 1986 Mar; 116(9):265-70. PubMed ID: 3952483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.